---
title: "002524.SZ (002524.SZ) — Related News"
type: "Symbol"
locale: "en"
url: "https://longbridge.com/en/quote/002524.SZ/news.md"
symbol: "002524.SZ"
name: "002524.SZ"
parent: "https://longbridge.com/en/quote/002524.SZ.md"
datetime: "2026-05-21T17:41:44.236Z"
locales:
  - [en](https://longbridge.com/en/quote/002524.SZ/news.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/002524.SZ/news.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/002524.SZ/news.md)
---

# 002524.SZ (002524.SZ) — Related News

### [GZYK revised its performance forecast for the fiscal year 2025, expecting a net loss of between 20 million yuan and 15 million yuan](https://longbridge.com/en/news/279926780.md)
*2026-03-20T10:20:08.000Z*
> GZYK released a revised announcement for the 2025 annual performance forecast, expecting a net profit of -20 million yua

### [ZEISS Vision Care and Medical Eyeglass Center Form Strategic Partnership, Combining Optical Excellence with Patient-Centric Operational Systems](https://longbridge.com/en/news/277677287.md)
*2026-03-03T20:38:00.000Z*
> ZEISS Vision Care has formed a strategic partnership with Medical Eyeglass Center (MEC) to enhance optical care and pati

### [GZYK: Subsidiary engages in financing business, with total company guarantees nearing 500 million yuan](https://longbridge.com/en/news/264404093.md)
*2025-11-05T10:45:01.000Z*
> GZYK announced that in 2025, the company and its holding subsidiaries plan to apply for a comprehensive credit line of n

### [Zhitong A-share lock-up release overview | October 27](https://longbridge.com/en/news/262794436.md)
*2025-10-27T01:01:05.000Z*
> On October 27th, a total of 10 listed companies had their restricted shares unlocked, with a total market value of appro

### [GZYK released its performance for the first three quarters, with a net profit attributable to the parent company of 173,400 yuan, a year-on-year increase of 100.83%](https://longbridge.com/en/news/262383549.md)
*2025-10-23T08:54:03.000Z*
> According to the Zhitong Finance APP, GZYK released its third-quarter report for 2025. In the first three quarters, the 

### [GZYK: Net profit loss of RMB 1.2455 million in the third quarter, a decrease of 94.36%](https://longbridge.com/en/news/262377338.md)
*2025-10-23T08:27:41.000Z*
> GZYK announced that the revenue for the third quarter was 227 million yuan, an increase of 4.82% year-on-year; the net p

### [GZYK's subsidiary applies for credit, with the cumulative guarantee amount accounting for 453.50% of net assets](https://longbridge.com/en/news/256866763.md)
*2025-09-11T07:53:32.000Z*
> GZYK announced that its wholly-owned subsidiary Zhongxing Ophthalmology and New Vision Ophthalmology applied for a credi

### [The performance differentiation in the ophthalmology medical industry is intensifying, and technological innovation has become the key to breaking through](https://longbridge.com/en/news/255564021.md)
*2025-09-02T07:34:12.000Z*
> The performance differentiation in the ophthalmology medical industry is intensifying, with technological innovation bec

### [Ophthalmology medical concept stocks surged, SPAS hit the daily limit in the afternoon](https://longbridge.com/en/news/255405475.md)
*2025-09-01T05:54:11.000Z*
> Ophthalmology medical concept stocks surged during the session, with SPAS hitting the daily limit, Xingqi Eye Medicine r